Orally taken traditional Chinese medicine composite for treating bladder cancer

Abstract

The invention discloses an orally taken traditional Chinese medicine composite for treating bladder cancer, belonging to a traditional Chinese medicine preparation. The invention is characterized in that the composite is prepared from the following raw materials calculated by weight: 30g of tuckahoe, 25g of giant knotweed, 25g of oldenlandia diffusa, 25g of radix astragali, 25g of yam, 12g of dogwood, 10g of dodder, 10g of angelica, 10g of Cimicifuga foetida, 10g of radix pseudostellariae, 10g of phellodendron and 10g of Rhizoma Zedoariae. The composite has the action of tonifying qi, strengthening the body resistance, activating blood and dissolving stasis and clearing away heat evil and promoting diuresis, and can effectively control the diffusion and transfer of cancer cells, improve the body immunity without toxic or side effects.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating bladder cancer, which belongs to the field of traditional Chinese medicines. Background technique [0002] Bladder tumors are the most common tumors in the urinary system. In developed countries or regions, the incidence rate is relatively high. The incidence rate of bladder tumors in foreign countries is second only to prostate cancer among male genitourinary tumors, ranking second; it occupies the first place in China, and it has increased in recent years. Bladder cancer mostly occurs between the ages of 40 and 60, and the number of men is three times that of women. Clinically, the disease is mainly manifested as painless hematuria and urinary tract irritation, which can also cause dilation of the ureter, and then form hydronephrosis. [0003] Western medicine surgery is generally used for the disease at present, and then combined with radiother...

AI Technical Summary

Problems solved by technology

[0003] Western medicine surgery is generally used for the disease at present, and then combined with radiotherapy and chemotherapy for treatment, but the phenomenon of recurrence after surgery is common, and the toxic side effects of radiotherapy and chemotherapy often cause severe damage to the patient's organs, and the immune mechanism declines sharply, so chemotherapy has to be interrupted